Frank Pallone actually said...
the imbalance of inspection requirements between U.S. and foreign manufacturing facilities creates an uneven playing field for pharmaceutical plants in the U.S.
Context
Pallone discusses the need for equal inspection standards for U.S. and foreign pharmaceutical manufacturers.
02/08/2012